Effect of Incorporating 1 Avocado Per Day Versus Habitual Diet on Visceral Adiposity: A Randomized Trial.
avocado
habitual diet
randomized clinical trial
risk factors for cardiometabolic disorders
visceral fat
Journal
Journal of the American Heart Association
ISSN: 2047-9980
Titre abrégé: J Am Heart Assoc
Pays: England
ID NLM: 101580524
Informations de publication
Date de publication:
19 07 2022
19 07 2022
Historique:
entrez:
21
7
2022
pubmed:
22
7
2022
medline:
26
7
2022
Statut:
ppublish
Résumé
Background Excess visceral adiposity is associated with increased risk of cardiometabolic disorders. Short-term well-controlled clinical trials suggest that regular avocado consumption favorably affects body weight, visceral adiposity, and satiety. Methods and Results The HAT Trial (Habitual Diet and Avocado Trial) was a multicenter, randomized, controlled parallel-arm trial designed to test whether consuming 1 large avocado per day for 6 months in a diverse group of free-living individuals (N=1008) with an elevated waist circumference compared with a habitual diet would decrease visceral adiposity as measured by magnetic resonance imaging. Secondary and additional end points related to risk factors associated with cardiometabolic disorders were assessed. The primary outcome, change in visceral adipose tissue volume during the intervention period, was not significantly different between the Avocado Supplemented and Habitual Diet Groups (estimated mean difference (0.017 L [-0.024 L, 0.058 L],
Identifiants
pubmed: 35861827
doi: 10.1161/JAHA.122.025657
pmc: PMC9707833
doi:
Substances chimiques
Cholesterol, HDL
0
Cholesterol, LDL
0
Banques de données
ClinicalTrials.gov
['NCT03528031']
Types de publication
Journal Article
Multicenter Study
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e025657Références
Nutr Diabetes. 2016 Jul 18;6(7):e221
pubmed: 27428873
Contemp Clin Trials. 2021 Nov;110:106565
pubmed: 34496276
Am J Clin Nutr. 1999 Jan;69(1):30-42
pubmed: 9925120
Clin Chem. 1973 May;19(5):476-82
pubmed: 4703655
Am J Clin Nutr. 2005 Aug;82(2):320-6
pubmed: 16087974
Clin Chem. 1974 Apr;20(4):470-5
pubmed: 4818200
Nutr J. 2013 Jan 02;12:1
pubmed: 23282226
Circulation. 2008 Apr 1;117(13):1658-67
pubmed: 18362231
Int J Obes (Lond). 2015 Jul;39(7):1109-13
pubmed: 25394308
J Am Heart Assoc. 2022 Apr 5;11(7):e024014
pubmed: 35352568
Br J Nutr. 2003 Sep;90(3):717-27
pubmed: 13129479
Nutr J. 2013 Nov 27;12:155
pubmed: 24279738
PLoS One. 2015 Oct 16;10(10):e0140846
pubmed: 26474158
J Clin Lipidol. 2016 Jan-Feb;10(1):161-71
pubmed: 26892133
Eur Radiol. 2009 Aug;19(8):2033-40
pubmed: 19280194
Nat Rev Endocrinol. 2020 Mar;16(3):177-189
pubmed: 32020062
Int J Obes (Lond). 2012 Nov;36(11):1455-62
pubmed: 22249228
Int J Obes (Lond). 2009 Dec;33(12):1419-26
pubmed: 19736556
Food Res Int. 2020 Dec;138(Pt A):109774
pubmed: 33292952
Clin Chem. 1972 Jun;18(6):499-502
pubmed: 4337382
Prog Lipid Res. 2017 Jul;67:1-15
pubmed: 28389247
Int J Obes (Lond). 2021 Aug;45(8):1740-1750
pubmed: 33986458
Nutr Res. 2022 Jun;102:45-58
pubmed: 35405602
Diabetes Care. 2007 Jul;30(7):1717-23
pubmed: 17384344
Am J Clin Nutr. 2018 Apr 1;107(4):523-536
pubmed: 29635493
J Nutr. 2021 Sep 4;151(9):2513-2521
pubmed: 34191028
Circulation. 2005 Oct 25;112(17):2735-52
pubmed: 16157765
Prev Chronic Dis. 2019 Jan 03;16:E02
pubmed: 30605422
Eur J Clin Nutr. 2013 Dec;67(12):1298-302
pubmed: 24149442
J Obes. 2019 Nov 3;2019:2193723
pubmed: 31781386
J Am Diet Assoc. 1997 Oct;97(10):1139-48, 1151; quiz 1149-50
pubmed: 9336561
Eur J Clin Nutr. 2012 Dec;66(12):1351-5
pubmed: 23093345
Eur Heart J. 2018 Feb 1;39(5):397-406
pubmed: 29020414
Curr Dev Nutr. 2019 Jun 12;3(8):nzz068
pubmed: 31367691